SNY250516P75000
- 0.00
- 0.000.00%
Sanofi Newsroom
Express News | Hawaii Says It Has Entered $700 Million Settlement With Pharmaceutical Firms Bristol-Myers Squibb and Units of French Pharmaceutical Company Sanofi - Statement
Pharma Worries Shift to Prices From Trade. Trump's Next Plan Could Sink Stocks. -- Barrons.com
Kymera Therapeutics: 1Q Revenue Attributable to the Company's Sanofi Collaboration >KYMR
Sanofi (SNY.US) has reported the launch of a new antibody drug.
Caplacizumab is a nanobody targeting vWF, designed to inhibit the interaction between vWF and platelets.
FDA to Speed up AI Rollout to Accelerate Drug Reviews
COVID Vaccine Maker Novavax Stock Soars 16% - Here's Why
Novavax Rises After Massive Q1 Beat, Guidance Raise
Sanofi To Go Ex-Dividend On May 9th, 2025 With 2.21215 USD Dividend Per Share
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
Trump Sets Pharma Tariffs Deadline. The Fallout for Lilly, Pfizer, Other Drugmakers
Moody's Upgrades Sanofi's Ratings, Changes Outlook to Stable
Sanofi Approves 2024 Financials and Announces Dividend at AGM
6-K: Annual General Meeting of April 30, 2025
French Stocks Reverse Two-Session Winning Streak
Notable Healthcare Headlines for the Week: Gilead, CVS Health, Sanofi in Focus
Sanofi Consumer Healthcare India Releases Q1 2025 Financial Results
Sanofi: Information Concerning the Total Number of Voting Rights and Shares - March 2025
Sanofi (ENXTPA:SAN) Announces €4 Per Share Dividend And New Compensation Committee Chair
Sanofi Treatment of Multiple Myeloma Granted FDA Orphan Status
Zucara Therapeutics Announces Second and Final Closing of US$25 Million Series B Financing